Biotech solutions company
ALung Technologies has raised €34M across 1 funding round from 8 investors, most recently a Series C round in Apr 2017. Based in UK; active in Healthtech. Data as of 6 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2017-04-12 | Series C |
| €34M |
| Abiomed,Allos Ventures,and Riverfront Ventures.,Birchmere Ventures,Blue Tree Ventures,Philips+2 more |
| View deal → |
